Peroxigard™

COVID-19
Products
Resources
News & Insights
Blog
About
- Our Story
- Contact

COVID-19
Products
Resources
News & Insights
Blog
About
- Our Story
- Contact

LATEST ARTICLES

Staphylococcus aureus (Community Acquired Methicillin Resistant Genotype USA 400 (CA-MRSA 400))

Mario Z May 26, 2021

Popular Articles

Peroxigard™ (US) efficacy against Monkeypox Virus (MPV)

August 22, 2022In cases of emerging viral pathogens such as Monkeypox Virus, when there is...Read more

Virox Technologies partners with Contec to expand delivery of sustainable, effective disinfectants to Lab Animal Sciences/Vivarium Market

August 16, 2022Virox Technologies, the creator and manufacturer of some of the world’s safest, most...Read more

Technical Bulletin – Cleaning and Disinfecting with Peroxigard™ to Prevent the Spread of Corynebacterium bovis

April 6, 2022Corynebacterium bovis (C. bovis), which causes scaly skin disease in rodents, poses a...Read more

Subscribe to our Blog

Popular Articles

Popular Articles

Nothing to Show Right Now

Popular Articles

Popular Articles

Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation With Biocidal Agents

February 28, 2020Accelerated Hydrogen Peroxide® was included in a recent study investigating the ability of...Read more

Going Green and Staying Clean: Using Accelerated Hydrogen Peroxide as a Disinfectant in Rodent Facilities

November 11, 2018The purpose of this study was to determine if Accelerated Hydrogen Peroxide is...Read more

Theoretical and Experimental Aspects of Microbicidal Activities of Hard Surface Disinfectants: Are Their Label Claims Based on Testing Under Field Conditions?

October 11, 2018For surface disinfection, the testing and label claims of many common disinfectants do...Read more

COVID-19
PRODUCTS
RESOURCES
OUR STORY
CONTACT US

Peroxigard Logo is a registered trademark of Virox Technologies Inc., the developer of the AHP^® technology.
© Virox Technologies Inc. All rights reserved. Proud member of AALAS General Conditions of Use | Privacy Policy

SOLUTIONS FOR C.BOVIS